Reports
Showing 1-7 of 7 Publications
-
AI and the Evolution of Biological National Security Risks
Reports
New AI capabilities may reshape the risk landscape for biothreats in several ways. AI is enabling new capabilities that might, in theory, allow advanced actors to optimize bio...
By Bill Drexel & Caleb Withers
-
Biotech Matters: Problems with Life Science Databases in the United States
Reports
While humans will retain their ultimate mysteries, many aspects of their traits, diseases, and environment are becoming increasingly tractable. Much of this advance has come f...
By Carol Kuntz
-
Biotech Matters: Public-Private Coordination of Biotechnology
Reports
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Reports
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko
-
Biotech Matters: Innovation in Agricultural Biotechnology
Reports
In 1986, the United States established a “Coordinated Framework for the Regulation of Biotechnology.” In the decades since, this policy helped to enable the rapid development ...
By Dr. L. Val Giddings
-
Biotech Matters: Automated Scientists Will Power Tomorrow’s Bioeconomy
Reports
Twenty years ago, it was barely plausible that soon every person on Earth would have a supercomputer in their pocket with ready access to the world’s information. Even though ...
By Dr. David A. Markowitz
-
Biotech Matters
Reports
Operation Warp Speed showed the power of the U.S. government to direct national biotech capabilities around a shared goal—in this case, a novel vaccine. But there are many oth...
By Hannah Kelley
